Bioinformatics Approach for Dementia

Alzheimer's disease (AD) is the most common form of dementia, with no disease-modifying treatment yet available. Early detection of patients at risk of developing AD is of central importance. Blood-based genetic signatures can serve as early detection and as population-based screening tools. Alzheimer’s disease (AD) is a serious degenerative brain disease and the most common cause of dementia. The current available drugs for AD provide symptomatic benefit, but there is no effective drug to cure the disease. The emergence of large-scale genomic, pharmacological data provides new opportunities for drug discovery and drug repositioning as a promising strategy in searching novel drug for AD.

Alzheimer’s disease is a progressive neurodegenerative disorder characterized by deposition of amyloid plaques composed of aggregated amyloid beta plaques, and neurofibrillary tangles composed of hyperphosphorylated tau that leads to synaptic defects resulting in neuritic dystrophy and neuronal death.

 

  • Proteomics in Dementia
  • Transcriptomics in Dementia
  • Epigenomics of Dementia
  • Data Mining Methods for Diagnosis of Dementia

Related Conference of Bioinformatics Approach for Dementia

August 13-14, 2024

14th Global Alzheimers Summit

Amsterdam, Netherlands
August 26-27, 2024

5th World Congress on Sleep Disorders and Therapeutics

Singapore City, Singapore
September 09-10, 2024

30th International conference on Neurosurgery

Paris, France
September 19-20, 2024

38th European Neurology Congress

Paris, France
September 23-24, 2024

11th Annual congress on Stroke and Neurological Disorders

Amsterdam, Netherlands
October 23-24, 2024

6th World Brain Congress

Paris, France
October 31-01, 2024

7th Global Congress on Spine and Spinal Disorders

Amsterdam, Netherlands
October 31-01, 2024

36th World Neuroscience and Neurology Conferences

Amsterdam, Netherlands
November 13-14, 2024

31st Cognitive Neuroscience Congress

Dubai, UAE
November 25-26, 2024

19th Annual Congress on Neuroscience

Aix-en-Provence, France
November 26-27, 2024

4th Annual Dementia Congress

Paris, France
December 05-06, 2024

9th Annual Congress on Pediatric Neurology and Pediatric Surgery

Prague, Czech Republic
December 05-06, 2024

7th World Congress on Epilepsy and Brain Disorders

Dubai, UAE
December 11-12, 2024

9th World Congress on Spine and Spinal Disorders

Paris, France
December 12-13, 2024

36th World Congress on Neurorehabilitation

London, UK
February 03-04, 2025

37th World Conference on Neurology

London, UK
February 17-18, 2025

17th International Conference on Neurology and Neuromuscular Disorders

Aix-en-Provence, France
February 17-18, 2025

5th International Conference on Child Neurology

Aix-en-Provence, France
February 20-21, 2025

6th International Conference on Neurologists

Amsterdam, Netherlands
February 24-25, 2025

4th International Conference onAlzheimer and Dementia

Madrid, Spain
February 27-28, 2025

7th World Depression Congress

Paris, France
March 10-11, 2025

8th World Conference on Neuroscience

Paris, France
March 13-14, 2025

7th World Conference on Neuroscience

Prague, Czech Republic
March 24-25, 2025

38th European Neurology Congress 2025

London, UK
April 23-24, 2025

6th International Summit on Mental Disorders and Illness

Aix-en-Provence, France

Bioinformatics Approach for Dementia Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in